We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Brazil’s Anvisa Offers Expedited Pathway for Generics Approvals
Brazil’s Anvisa Offers Expedited Pathway for Generics Approvals
Drugmakers planning to market generic and biosimilar products in Brazil should pair up with the branded firms to facilitate the application process, according to an updated rule aimed at speeding generic approvals.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor